PubRank

R C Desrosiers

Author PubWeight™ 364.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991 13.69
2 Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998 12.81
3 Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000 9.80
4 Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992 9.30
5 Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985 9.27
6 Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995 8.15
7 Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 1987 7.96
8 Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985 6.02
9 The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990 5.79
10 A role for carbohydrates in immune evasion in AIDS. Nat Med 1998 5.06
11 Progression to AIDS in the absence of a gene for vpr or vpx. J Virol 1995 3.96
12 Four novel U RNAs are encoded by a herpesvirus. Cell 1988 3.86
13 Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996 3.84
14 Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 1985 3.74
15 Significance of premature stop codons in env of simian immunodeficiency virus. J Virol 1989 3.60
16 Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol 1991 3.46
17 Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 2001 3.40
18 Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci U S A 1979 3.24
19 Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol 1987 3.18
20 Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol 1992 3.16
21 Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat Med 1997 3.11
22 The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol 1992 3.09
23 Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 1995 3.03
24 Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A 1992 2.94
25 Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol 1997 2.90
26 Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses 1994 2.72
27 Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol 1993 2.70
28 Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol 1999 2.69
29 Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol 1993 2.65
30 Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 1999 2.65
31 Titration and characterization of two rhesus-derived SIVmac challenge stocks. AIDS Res Hum Retroviruses 1994 2.63
32 High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996 2.61
33 Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J 1986 2.60
34 Comparison of simian immunodeficiency virus isolates. Nature 1988 2.55
35 Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J Virol 1986 2.52
36 A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 1997 2.41
37 Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 1998 2.38
38 Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997 2.34
39 Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol 1989 2.33
40 Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol 1989 2.29
41 The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 1990 2.28
42 Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 1997 2.27
43 Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol 1984 2.25
44 A region of the Herpesvirus saimiri genome required for oncogenicity. Science 1985 2.22
45 A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science 1984 2.22
46 Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses 1994 2.18
47 Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci U S A 1991 2.18
48 The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol 2000 2.15
49 Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri. J Virol 1984 2.14
50 Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation. J Virol 1984 2.09
51 Virus-encoded cyclin. Mol Cell Biol 1994 2.06
52 Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol 2000 2.04
53 The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1992 2.00
54 Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus. Biochemistry 1975 1.96
55 Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. J Virol 2001 1.95
56 Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol 1998 1.90
57 Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol 1984 1.89
58 Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J Virol 1991 1.84
59 Herpesvirus saimiri strain variability. J Virol 1982 1.80
60 Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol 1993 1.77
61 Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol 1994 1.77
62 Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol 1997 1.71
63 Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol 1994 1.70
64 A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res Hum Retroviruses 1992 1.70
65 Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999 1.69
66 Association of the viral oncoprotein STP-C488 with cellular ras. Mol Cell Biol 1995 1.66
67 Sexual transmission of SIVagm in wild grivet monkeys. J Med Primatol 1994 1.63
68 Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann Neurol 1988 1.63
69 Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J Virol 2000 1.57
70 Herpesvirus saimiri DNA in tumor cells--deleted sequences and sequence rearrangements. J Virol 1981 1.55
71 Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol 1987 1.54
72 Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization. Am J Pathol 1989 1.52
73 A gene for dihydrofolate reductase in a herpesvirus. Science 1988 1.47
74 Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J Virol 1999 1.47
75 Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol 2000 1.47
76 Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. Virology 1993 1.45
77 STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol 1998 1.45
78 AIDS biosafety. Science 1991 1.44
79 Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr Top Microbiol Immunol 1994 1.43
80 Identification of Lck-binding elements in tip of herpesvirus saimiri. J Biol Chem 1995 1.43
81 Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. J Clin Invest 1986 1.43
82 Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol 1999 1.42
83 Direct demonstration of retroviral recombination in a rhesus monkey. J Virol 1997 1.41
84 Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J Virol 1999 1.41
85 The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. J Virol 1994 1.40
86 Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 1998 1.39
87 Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J Virol 1998 1.39
88 Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements. J Virol 1996 1.39
89 Extensive genetic variability of simian immunodeficiency virus from African green monkeys. J Virol 1989 1.37
90 The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol 1994 1.36
91 Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome. Am J Pathol 1987 1.32
92 Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol 1998 1.31
93 Specifically unmethylated cytidylic-guanylate sites in Herpesvirus saimiri DNA in tumor cells. J Virol 1982 1.29
94 Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review. J Med Primatol 1990 1.29
95 HIV-1 origins. A finger on the missing link. Nature 1990 1.26
96 High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res Hum Retroviruses 1994 1.26
97 Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity. J Virol 1994 1.25
98 Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys. AIDS Res Hum Retroviruses 1999 1.24
99 Prevalence of antibodies to SIV in baboons in their native habitat. AIDS Res Hum Retroviruses 1989 1.23
100 Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239. Am J Pathol 1996 1.22
101 Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2. J Gen Virol 1990 1.22
102 The productive infection of alveolar macrophages by simian immunodeficiency virus. J Med Primatol 1989 1.21
103 A PCR-based strategy for extensive mutagenesis of a target DNA sequence. Biotechniques 1993 1.21
104 Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus. EMBO J 1998 1.21
105 Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J Virol 1995 1.21
106 Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses 1998 1.20
107 Animal models for acquired immunodeficiency syndrome. Rev Infect Dis 1987 1.19
108 Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J Virol 1998 1.18
109 Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239. J Virol 2001 1.17
110 Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol 2001 1.17
111 Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol 1997 1.17
112 Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J Virol 2000 1.16
113 Herpesvirus saimiri strain 11 immortalizes a restricted marmoset T8 lymphocyte subpopulation in vitro. J Exp Med 1986 1.15
114 AIDS vaccine developments. Nature 1992 1.15
115 Lymphoma in macaques: association with virus of human T lymphotrophic family. Science 1984 1.15
116 Mapping of RNA transcribed from a region of the Herpesvirus saimiri genome required for oncogenicity. J Virol 1984 1.14
117 Transformation of owl monkey T cells in vitro with Herpesvirus saimiri. Proc Natl Acad Sci U S A 1984 1.14
118 Effect of simian immunodeficiency virus infection on tumor necrosis factor-alpha production by alveolar macrophages. Lab Invest 1991 1.14
119 Simian homologues of human herpesvirus 8. Philos Trans R Soc Lond B Biol Sci 2001 1.14
120 The value of specific pathogen-free rhesus monkey breeding colonies for AIDS research. AIDS Res Hum Retroviruses 1997 1.14
121 Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses. Proc Natl Acad Sci U S A 1996 1.13
122 Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus. J Virol 1991 1.13
123 Requirements for lymphocyte activation by unusual strains of simian immunodeficiency virus. J Virol 1996 1.12
124 Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys. J Virol 1999 1.12
125 Improved recombinant PCR mutagenesis procedure that uses alkaline-denatured plasmid template. Biotechniques 1995 1.11
126 Distinct functional domains of STP-C488 of herpesvirus saimiri. Virology 1994 1.11
127 Epithelial tumours induced by a herpesvirus oncogene in transgenic mice. Oncogene 1994 1.10
128 Lymphoproliferative syndrome in an immunodeficient rhesus monkey naturally infected with an HTLV-III-like virus (STLV-III). Lab Invest 1986 1.09
129 Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol 1977 1.08
130 Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements. J Virol 1997 1.07
131 Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge. J Med Primatol 2002 1.07
132 Species specificity of macaque rhadinovirus glycoprotein B sequences. J Virol 2000 1.07
133 Immunopathogenesis of SIVmac. Virus Res 1994 1.06
134 Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J Virol 1997 1.05
135 Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine. AIDS Res Hum Retroviruses 1994 1.03
136 Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 1992 1.03
137 Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort. J Infect Dis 1999 1.03
138 Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication. J Virol 2001 1.02
139 Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol 1985 1.00
140 Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques. J Med Primatol 2004 1.00
141 Nef genes of SIV. J Med Primatol 1990 1.00
142 A role for herpesvirus saimiri orf14 in transformation and persistent infection. J Virol 1998 0.99
143 Prospects for live attenuated HIV. Nat Med 1998 0.99
144 A mutation in integrase can compensate for mutations in the simian immunodeficiency virus att site. J Virol 1997 0.99
145 Experimental infection of rhesus monkeys with type D retrovirus. J Virol 1984 0.98
146 Immune evasion strategies of the primate lentiviruses. Immunol Rev 2001 0.97
147 Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus. Virology 1995 0.97
148 Molecular changes associated with replication of simian immunodeficiency virus in human cells. J Med Primatol 1990 0.96
149 Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes. J Virol 1993 0.96
150 Retrovirus D/New England and its relation to Mason-Pfizer monkey virus. J Virol 1985 0.95
151 Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses 1994 0.95
152 Simian models for AIDS. Cancer Detect Prev Suppl 1987 0.95
153 Detection of simian immunodeficiency virus in macaque lymph nodes with a SIVmac envelope probe. J Med Primatol 1989 0.94
154 EGFP-containing vector system that facilitates stable and transient expression assays. Biotechniques 1997 0.94
155 Herpesvirus tamarinus and its relation to herpes simplex virus. J Gen Virol 1981 0.93
156 Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 1997 0.92
157 Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus. J Virol 2000 0.92
158 Nucleotide methylation patterns in eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol 1976 0.92
159 RNA from unique and repetitive DNA sequences of Herpesvirus saimiri. Virology 1980 0.92
160 Soluble and membrane-associated interleukin 2 receptor-alpha expression in rhesus monkeys infected with simian immunodeficiency virus. Lab Invest 1990 0.91
161 A radiation hybrid mapping panel for the rhesus macaque. J Hered 2002 0.91
162 Origins of HTLV-4. Nature 1987 0.89
163 Herpesvirus saimiri oncogene STP-C488 encodes a phosphoprotein. J Virol 1992 0.88
164 Cytokine influence on simian immunodeficiency virus replication within primary macrophages. TNF-alpha, but not GMCSF, enhances viral replication on a per-cell basis. Am J Pathol 1991 0.88
165 Use of simian immunodeficiency virus for vaccine research. J Med Primatol 1990 0.87
166 Use of infectious molecular clones of simian immunodeficiency virus for pathogenesis studies. J Med Primatol 1989 0.86
167 Mutation of the Lck-binding motif of Tip enhances lymphoid cell activation by herpesvirus saimiri. J Virol 1998 0.85
168 Difference in 5' terminal structure between the mRNA and the double-stranded virion RNA of reovirus. Biochem Biophys Res Commun 1976 0.85
169 Trans-activation of long terminal repeat sequence-mediated gene expression is not a property of type D retrovirus replication. J Gen Virol 1987 0.85
170 Genetic diversity of simian immunodeficiency virus. J Med Primatol 1989 0.84
171 Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus. J Virol 1990 0.84
172 Episomal and nonepisomal herpesvirus DNA in lymphoid tumor cell lines. Haematol Blood Transfus 1981 0.84
173 Seroprevalence of HIV-1 and HIV-2 in Guinea Bissau in 1980. AIDS 1988 0.84
174 Infection of baboons with human immunodeficiency virus-2 (HIV-2) J Infect Dis 1987 0.84
175 Characterization of the cutaneous exanthem in macaques infected with a Nef gene variant of SIVmac239. J Invest Dermatol 1998 0.84
176 Identification of V3 mutations that can compensate for inactivating mutations in C4 of simian immunodeficiency virus. Virology 1995 0.82
177 Transformation by herpesvirus saimiri. Adv Cancer Res 1991 0.82
178 The tax gene sequences form two divergent monophyletic lineages corresponding to types I and II of simian and human T-cell leukemia/lymphotropic viruses. Virology 1997 0.81
179 Effects of reverse-transcriptase mutations M184V and E89G on simian immunodeficiency virus in Rhesus monkeys. J Infect Dis 2001 0.81
180 The immunopathogenesis of retroviral diseases: no immunophenotypic alterations in T, B, and NK cell subsets in SIVmac239-challenged rhesus macaques protected by SIV delta nef vaccination. J Med Primatol 1996 0.81
181 SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication. AIDS Res Hum Retroviruses 1994 0.80
182 A case of pulmonary cestodiasis in a simian immunodeficiency virus-infected pigtailed macaque (Macaca nemestrina) in which virus-infected leukocytes are present within the lesion. J Med Primatol 1996 0.80
183 Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates. J Immunol 1991 0.80
184 Genes for the synthesis of deoxythymidylate monophosphate in T-cell lymphoma-inducing herpesviruses of nonhuman primates. Curr Top Microbiol Immunol 1989 0.80
185 The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res 1993 0.79
186 A PCR-derived library of random point mutations within the V3 region of simian immunodeficiency virus. PCR Methods Appl 1993 0.79
187 Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. AIDS 1989 0.79
188 Sequence variability of simian immunodeficiency virus in a persistently infected rhesus monkey. J Med Primatol 1990 0.79
189 Viral transformation of human T lymphocytes. Adv Cancer Res 1994 0.78
190 Herpesvirus saimiri U RNA sequence variation. Nucleic Acids Res 1990 0.77
191 Differences in neutralization of simian lentivirus (SIVMAC) in lymphocyte and macrophage cultures. AIDS Res Hum Retroviruses 1992 0.77
192 Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary. J Int Assoc Physicians AIDS Care 1998 0.77
193 Impairment of reovirus mRNA 'cap' methylation in interferon-treated mouse L929 cells. Biochim Biophys Acta 1979 0.77
194 The sensitivity of RNA polymerases I and II from Novikoff hepatoma (N1S1) cells to 3'-deoxyadenosine 5'-triphosphate. Nucleic Acids Res 1976 0.75
195 Approaches to AIDS research. Science 1997 0.75
196 Origin of the human AIDS virus. Nature 1986 0.75
197 Relative importance and functional role of genetic elements targeted for a live attenuated AIDS vaccine. Antibiot Chemother (1971) 1996 0.75
198 Random mutagenesis of short target DNA sequences via PCR with degenerate oligonucleotides. Methods Mol Biol 1996 0.75
199 Nonhuman primate lentiviruses: models for human infection. Dev Biol Stand 1990 0.75